Indication
Well Differentiated and Progressive
1 clinical trial
3 products
Clinical trial
AN OBSERVATIONAL REAL-WORLD STUDY OF THE SYSTEMIC TREATMENT OF WELL-DIFFERENTIATED, UNRESECTABLE OR METASTATIC, PROGRESSIVE PANCREATIC NEUROENDOCRINE TUMOURS (PNET): A STUDY OF MORBIDITY AND MORTALITY AT 2 YEARSStatus: Completed, Estimated PCD: 2019-11-18
Product
everolimusProduct
sunitinib